T2 Biosystems, Inc
TTOO
TTOO was delisted on the 11th of February, 2025.
48 hedge funds and large institutions have $27.6M invested in T2 Biosystems, Inc in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 23 closing their positions.
119% more call options, than puts
Call options by funds: $437K | Put options by funds: $200K
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
3% less capital invested
Capital invested by funds: $28.6M → $27.6M (-$986K)
24% less funds holding
Funds holding: 63 → 48 (-15)
65% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 23
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$530K |
| 2 |
GS
Gagnon Securities
New York
|
+$385K |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$353K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$321K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$169K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$3.09M |
| 2 |
SM
Senvest Management
New York
|
-$1.49M |
| 3 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$1.47M |
| 4 |
JP Morgan Chase
New York
|
-$1.17M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.01M |
TTOO Hedge Fund Activity: Q3 2019 in Review
48 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2019, worth a combined $27.6M — down 3.5% from $28.6M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of TTOO and 8 opened new positions — a net loss of 15 holders — while 10 trimmed existing stakes and 14 added.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $530K. The largest seller was Polaris Venture Management Co V, exiting entirely with an estimated $3.09M sold.
- 48 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2019, down from 63 in Q2 2019.
- Funds reported $27.6M of T2 Biosystems, Inc stock for Q3 2019, down 3.5% quarter-over-quarter.
- 8 funds opened new T2 Biosystems, Inc positions in Q3 2019 and 23 closed out, a net change of -15 holders.
- The largest T2 Biosystems, Inc buyer in Q3 2019 was Essex Investment Management, an estimated $530K added.
- The largest T2 Biosystems, Inc seller in Q3 2019 was Polaris Venture Management Co V, an estimated $3.09M sold.
Based on aggregated 13F filings for Q3 2019.